Shionogi’s once-a-day Covid-19 anti-viral shows rapid virus clearance
A separate global Phase 3 study of S-217622 is underway aiming to recruit participants globally to support regulatory filings this year
A separate global Phase 3 study of S-217622 is underway aiming to recruit participants globally to support regulatory filings this year
Desidustat is currently approved only in India as OxemiaTM for patients with CKD induced anemia
Heavy bleeding after giving birth is globally a leading cause of death in new mothers
Pre-exposure prevention trial reduced risk of symptomatic Covid-19, with no severe disease or Covid-19-related deaths in the Evusheld group
To meet the growing global demand for respiratory active pharmaceutical ingredients (APIs), Inke is to invest €9 million into its production plant to reinforce focus on inhalation micronised APIs
Tc99m tilmanocept is designed for the precise identification of lymph nodes that drain from a primary tumor, which have the highest probability of harboring cancer
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
Through the contract, the company will supply two key GMP intermediates for one of the 'patented drugs' of the innovator pharmaceutical customer
The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa
New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia
Subscribe To Our Newsletter & Stay Updated